> BIOSPAIN
Press Releases

SHARE THIS INFORMATION

BioSpain 2016 will be the hub of Biotechnology in Autumm

The Biospain Investment Forum will have the support of the Spanish Venture Capital & Private Equity Association (ASCRI) in the organisation of the event, which aims to attract both national and international investors

Madrid. The Organising Committee of Biospain 2016, which is co-organised by the Spanish Bioindustry Association (ASEBIO) and SPRI, the Basque Business Development Agency (Department of Economic Development and Competitiveness of the Basque Government), has selected four scientific societies to organise the Scientific Congress at this event, that will take place in Bilbao from the 28th to the 30th of September this year.

The chosen societies are the Spanish Society for Immunology (SEI): the Spanish Society of Haematology and Haemotherapy (SEHH); the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Proteomics Society (SEPROT), the Spanish Biotechnology Society (SEBIOT) will also participate and is organising a parallel session.  

The SEI session will focus on immunotherapy and cell therapy; the SEHH session will centre on how haematology has become a pioneering technology in biotechnology; the SEIMC session will explore innovations in the diagnosis and treatment of multiple drug resistant bacterial infections; the SEPROT session will focus on the identification of biomarkers and targeted proteomics.   

Dr Francisco J.M. Mojica, a prestigious speaker and tenured Professor of Microbiology at the University of Alicante is already confirmed for Biospain. Mojica was the first researcher to characterise and coin the term CRISPR Technology, carrying out the first experiments into this gene editing technique with multiple biotechnology applications. 

Third edition of the Training and Employment Forum

The Biospain Organisational Committee has also reached a collaboration agreement with FEBiotec for the diffusion activities of the third edition of the Training and Employment Forum, collaborating through the dissemination of information for the event among its general membership and affiliated associations. The forum will go beyond showcasing training opportunities for the sector by making use of a system of scheduled interviews that will connect employers offering jobs and job hunters seeking new opportunities. There will also be a programme on career opportunities, in-demand profiles, and key factors when job hunting.     

Biospain Investment Forum

The Biospain Investment Forum will have the support of the Spanish Venture Capital & Private Equity Association (ASCRI) in the organisation of the event, which aims to attract both national and international investors. The collaboration will be focused around organising a specific parallel programme and social events for the investment community.  

70% of the commercial fair space is already allocated. Some of the most stand-out subject areas include: a patient forum on rare diseases, multiple sclerosis and the increasingly bigger role played by patient organisations; new diagnostics methods; vaccines; Alzheimer's; food and health; public policies for open innovation; nanobiotechnology; big data; new oncology therapies, and bioeconomy.

From the 28th to the 30th of September 2016 the Bilbao Exhibition Centre (BEC) in Barakaldo (Bilbao, Basque Country) will be the stage for BioSpain 2016, a forum for all the actors in the biotechnology sector to share knowledge, ideas and experiences. The event has become the main international platform for the showcasing of Spanish biotechnology and to provide answers for the commercial, academic and information needs of the sector.

BioSpain is made up of a commercial fair, a partnering event, an investment forum, a training and employment forum, conferences on a range of issues (with parallel sessions) attended by national and international speakers and a scientific conference which is organised by scientific societies. The event has now become the biggest country-based fair in Europe and the fifth biggest in the world in terms of the number of business development meetings.

The BEC has 150,000 m2 of space for commercial exhibitions distributed in six pavilions, 18.000m2 for conventions, several exhibition rooms, vestibules, a restaurant, cafe, car parking and other facilities - providing the perfect venue for an event like BioSpain.

Biospain is today the 5th largest partnering in biotechnology in the world, with 3.327 one-to-one meetings, +320% more meetings than the first time the partneringONE® system (EBD Group) was introduced in 2008.

Following the success of previous editions, Biospain 2014 hosted 200 exhibitors, more than 850 companies and institutions and over 1.850 delegates from 37 countries. One-to-one business meetings rose to 3.327 (+20%).

 

Participant Overview by Industry

 

·         Biotechnology..........................................................51%

o            Health......................................33%

o            Industrial...................................7%

o            Food...........................................6%

o            Agriculture.................................5%

·         Research Institutions/Universities/Clusters......11%

·         Pharma........................................................................10%

·         Investors.......................................................................8%

·         Profesional services & consulting...........................8%

·         Media.............................................................................5%

·         Medical Technology.....................................................2%

·         Suppliers & Engineering.............................................3%

 

 

 

 

For further information:

Lucía Cecilia

Head of Communications for ASEBIO and BioSpain 2016

Landline: +34 912109374/10

Mobile: +34 663 117 293   

email: lcecilia@asebio.com

www.asebio.com

Inversores de 11 países analizan 30 proyectos de biotecnología española 

Read more

El top ten de fondos de inversión asistentes a Biospain 2016 gestionan activos valorados en más de 5.000 millones de euros

Read more

The ten biggest funds at Biospain 2016 manage assets of over 5 billion euros

Read more

Los pacientes piden en Biospain 2016 una participación activa en las políticas de salud y en el sistema sanitario 

Read more

El descubrimiento del ‘GPS humano’ abre una nueva era en la ingeniería genética

Read more

La biotecnología agrícola, clave para afrontar el problema de la superpoblación y el cambio climático

Read more

Biospain 2016 ya cuenta con una APP gratuita para seguir el evento

Read more

US expects to increase its presence in Biospain 2016

Read more

Bilbao will host BioSpain 2016

Read more

Bilbao acogerá BioSpain 2016

Read more

EE.UU. prevé incrementar su presencia en Biospain 2016

Read more

BioSpain 2016 selecciona a cuatro sociedades científicas

Read more

El 82% de los asistentes a Biospain identificaron oportunidades reales de negocio

Read more

82% of participants at Biospain identified real business opportunities

Read more

La inmunoterapia se postula como uno de los pilares terapéuticos del cáncer

Read more

La bioimpresión 3D de tejidos tisulares acortará el tiempo de desarrollo de fármacos de 10 a tres años

Read more

La bioeconomía se consolida como una herramienta clave para afrontar los retos futuros del planeta

Read more

BioSpain 2014 incrementa un 43% su internacionalización sobre la edición anterior

Read more

BioSpain 2014 increases its internationalisation by 43% compared to the previous edition 

Read more

Participantes en Biospain de 16 países llegarán a la feria por el camino #Xacobio

Read more

La biotecnología agroalimentaria tendrá una importante presencia en BioSpain 2014

Read more

Biospain firma un acuerdo con Febiotec para la or-ganización del II Foro de Formación y Empleo

Read more

BioSpain 2014 amplía su Foro de Inversión con más perfiles de inversores y más empresas participantes

Read more

BioSpain 2014 expands its Investment Forum through wider range of investor profiles and more participating companies

Read more

BioSpain 2014 refuerza su presencia internacional e incorpora el modelo de “Innovación en abierto”

Read more

BioSpain 2014 strengthens its international presence and includes ‘Open Innovation’ model 

Read more

10 scientific and medical societies collaborate on Biospain 2014 programme 

Read more

10 scientific and medical societies collaborate on Biospain 2014 programme  

Read more

Biospain 2014 contará en su programa con la colaboración de 10 sociedades científicas y médicas

Read more

Biospain 2014 abre su programa de conferencias a las sociedades científicas y médicas

Read more

ASEBIO y la Xunta de Galicia sellan su colaboración en BioSpain 2014

Read more

ASEBIO and the Autonomous Government of Galicia seal their collaboration on BioSpain 2014

Read more

Santiago de Compostela será la capital europea de la biotecnología en 2014

Read more

Xacobio